Related Experiment Video
Updated: Dec 14, 2025

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
HUNK Signaling in Metastatic Breast Cancer
Tinslee Dilday1, Nicole Ramos1, Elizabeth Yeh1
1Department of Pharmacology and Toxicology, Indiana University School of Medicine, Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, USA.
Abstract:
Once metastatic disease has occurred, there is no cure for breast cancer. Consequently, identifying factors that promote and support breast cancer metastasis is critical for understanding how to pharmacologically target this process. Hormonally up-regulated neu-associated kinase (HUNK) is a serine/threonine protein kinase related to the sucrose non-fermenting-1 (Snf-1)/5' adenosine monophosphate-activated protein kinase (AMPK) family of kinases. HUNK has been found to play a role in breast cancer metastasis. However, conflicting reports indicate HUNK is a metastasis promoting factor as well as an inhibiting factor. Our group recently provided evidence that supports the conclusion that HUNK is a metastasis promoting factor by showing that HUNK regulates breast cancer metastasis through phosphorylation of EGFR. Here, we summarize our findings and discuss their implications toward pharmacological targeting of HUNK in breast cancer.
Insights
Hormonally up-regulated neu-associated kinase (HUNK) promotes breast cancer metastasis by phosphorylating EGFR. Targeting HUNK offers a potential therapeutic strategy for advanced breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Breast cancer metastasis is a leading cause of mortality with no cure once established.
- Identifying metastasis-promoting factors is crucial for developing targeted therapies.
- Hormonally up-regulated neu-associated kinase (HUNK) has conflicting roles reported in breast cancer metastasis.
Purpose of the Study:
- To elucidate the role of HUNK in breast cancer metastasis.
- To investigate the mechanism by which HUNK influences metastasis.
- To explore the therapeutic potential of targeting HUNK.
Main Methods:
- Investigated HUNK's role in breast cancer metastasis.
- Examined the phosphorylation of Epidermal Growth Factor Receptor (EGFR) by HUNK.
- Analyzed the implications for pharmacological targeting.
Main Results:
- Provided evidence that HUNK promotes breast cancer metastasis.
- Demonstrated that HUNK regulates metastasis through EGFR phosphorylation.
- Identified a specific mechanism linking HUNK activity to metastatic progression.
Conclusions:
- HUNK acts as a metastasis-promoting factor in breast cancer.
- Phosphorylation of EGFR by HUNK is a key mechanism in metastasis.
- Targeting HUNK presents a promising avenue for breast cancer treatment.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Hedgehog Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Canonical Wnt Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

